Esperion Theraptc (ESPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 981 | 982 | 145,419 | 0 | 0 |
| Gross Profit | 981 | 982 | 145,419 | N/A | N/A |
| Operating Expenses | 66,749 | 56,280 | 58,490 | 60,649 | 50,562 |
| Operating Income | -65,768 | -55,298 | 86,929 | -60,649 | -50,562 |
| Interest Expense | 3,996 | 0 | 0 | 0 | 0 |
| Other Income | 1,387 | 1,077 | 450 | 610 | 651 |
| Pre-tax Income | -68,377 | -54,221 | 87,379 | -60,039 | -49,911 |
| Net Income Continuous | -68,377 | -54,221 | 87,379 | -60,039 | -49,911 |
| Net Income | $-68,377 | $-54,221 | $87,379 | $-60,039 | $-49,911 |
| EPS Basic Total Ops | -2.52 | -2.01 | 3.26 | -2.24 | -1.86 |
| EPS Basic Continuous Ops | -2.52 | -2.01 | 3.26 | -2.24 | -1.86 |
| EPS Diluted Total Ops | -2.52 | -2.01 | 3.07 | -2.24 | -1.86 |
| EPS Diluted Continuous Ops | -2.52 | -2.01 | 3.07 | -2.24 | -1.86 |
| EBITDA(a) | $-65,695 | $-55,289 | $86,925 | $-60,658 | $-50,572 |